About the role
Job Description Summary
The HEOR Manager is responsible for generating and communicating health economic and real-world evidence to support pricing, reimbursement, and market access of pharmaceutical products in Belgium. It ensures payer-relevant evidence is generated, adapted, and submit-ted in line with Belgian payer requirements. The role leads or contributes to the development of local dossiers, economic models, and submissions working closely with cross functional teams. It engages with external stakeholders, including HTA bodies and health authorities, to support positive access outcomes. The role operates with high standards of operational ex-cellence, compliance and timely delivery.
Job Description
Major accountabilities:
HEOR Strategy
- Develop and implement local HEOR strategies aligned with brand and market access objectives.
- Identify evidence gaps relevant to Belgian reimbursement and payer decision-making.
- Advise on integration of HEOR evidence into brand planning and launch strategies
Health Economic Modelling
- Adapt or develop cost-effectiveness and budget impact models and reports for Belgium.
- Ensure models reflect Belgian clinical practice, epidemiology, resource use, costs, and reimbursement pathways.
- Work with global HEOR teams and/or external vendors to localize economic models.
- Critically review model assumptions, inputs, outputs, and sensitivity analyses.
- Support the preparation of economic evidence for reimbursement discussions.
Reimbursement and Market Access Support
- Provide HEOR input (models and reports) for submissions to Belgian reimbursement dossiers.
- Translate complex HEOR findings into clear, stakeholder-appropriate messages.
- Coordinate responses to HTA questions and requests.
- Ensure submission materials meet quality, timing, and compliance standards.
- Support pricing and reimbursement strategies with robust economic and outcomes evidence.
- Monitor Belgian healthcare policy, HTA requirements, reimbursement trends, and payer expectations.
- Support discussions related to managed entry agreements when needed.
- Support early launch activities
Scientific Communication
- Support development of scientific publications, congress abstracts, posters, and presentations.
Stakeholder Engagement & External Interface
- Engage with HTA bodies, payers, and health authorities as required.
- Represent the organization in HTA‑related meetings and consultations.
- Build professional, trust‑based relationships with external stakeholders.
- Collaborate with Public Affairs on HEOR and HTA landscape activities.
Cross‑functional Collaboration & Operational Excellence
- Work closely with Market Access, Medical, Pricing, Finance, and global HEOR teams.
- Coordinate internal contributors and external suppliers for HEOR deliverables
- Ensure on‑time, on‑budget delivery of HEOR activities
- Communicate strategy, risks, and progress to internal stakeholders
- Execute all activities in line with ethical, legal, and compliance requirements
Education:
- University degree in life sciences, health sciences, economics or business
- Advanced training in health economics or related field preferred
Languages:
- English
- Dutch and/or French: strongly preferred
Experience/Professional Requirement:
- ≥3 years’ experience in HEOR, HTA, market access
- Experience supporting reimbursement submissions and payer evaluations
- Experience with economic modelling (e.g. Excel, R) and evidence generation
- Excellent economic and analytical ability
- Ability to interpret clinical trial data, real-world evidence, and epidemiological data.
- Exposure to national healthcare systems and reimbursement processes
Functional capabilities
- Development or oversight of economic models and reports.
- Evidence generation, data interpretation, and analytical problem solving
- Project management with multiple stakeholders and suppliers
- Excellent written and verbal communication skills.
Skills Desired
Agility, Cross-Functional Collaboration, Data Analysis, Employee Development, External Orientation, Finance, Financial Analysis, Healthcare Sector Understanding, Health Economics, Health Policy, Health Technology Assessment (HTA), Innovation, Market Access Strategy, People Management, Pricing Strategy, Public Health, Real World Evidence (RWE), Regulatory Affairs, Reimbursement Strategy, Research Methodologies, Results-Oriented, Statistical Analysis, Strategic PartnershipsAplyr's read
Novartis is a Swiss-based global healthcare leader, known for its focus on innovative medicines and commitment to addressing patient needs through diverse roles.
What's promising
- •Novartis invests heavily in research and development, driving innovation in pharmaceuticals.
- •The company offers a wide range of global career opportunities across various fields.
- •Strong focus on cutting-edge therapies, including gene therapy and AI-driven solutions.
What to watch
- •Regulatory challenges can impact the speed of drug approval and market entry.
- •High competition in the pharmaceutical industry requires constant innovation to maintain market position.
- •Complex organizational structure may slow decision-making processes.
Why Novartis
- •Novartis has a robust pipeline of innovative medicines, setting it apart in the healthcare sector.
- •The company emphasizes a diverse and inclusive workplace culture across its global operations.
- •Novartis is a leader in digital transformation within pharmaceuticals, integrating AI and data science.
Aplyr’s read is generated by AI from public sources. Was it useful?
About Novartis
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide. It focuses on innovative medicines, generics, and eye care.
Similar roles
US Director of Health Economics Outcomes Research (Population Health)
BridgeBio Pharma
Senior Manager, Health Economics & Outcomes Research (Immunology)
Regeneron
Assoc Dir Health Economics & Outcomes Research, Solid Tumors
Regeneron
Director Health Economics and Outcomes Research (HEOR)
Novartis
Director, Health Economics and Outcomes Research (HEOR) – Oncology
Corcept Therapeutics
Director, Health Economics & Outcomes Research (HEOR)
Vaxcyte